1
0
0
News
Doppelte Antikörper-Blockade senkt Rezidivrisiko und Mortalität
www.aerzteblatt.de
Max Hasmann, Roche Diagnostics GmbH, Penzberg, zu verdanken. Nach etlichen Rückschlägen zeigte im Mausmodell die Kombination von Perjeta® und Herceptin® eine ... › archiv › HER2-positives-M...
Genentech Her2 Story
www.gene.com
The HER2 Journey: The inside story of a breast cancer breakthrough, 30 years in the making.
Netzwerk-Profile
LinkedIn: Max Hasmann - Deutschland | LinkedIn
Max Hasmann Preclinical Science Leader at Roche Location Munich Area, Germany Industry Pharmazie Werden Sie Mitglied von LinkedIn und erhalten Sie Zugriff auf das
LinkedIn: Max Hasmann | Berufsprofil - LinkedIn
Sehen Sie sich das Profil von Max Hasmann auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. Max Hasmann hat 1 Job im Profil angegeben. Sehen ...
Missing: uk
Max Hasmann | Semantic Scholar
www.semanticscholar.org
Semantic Scholar profile for ,, with 4 scientific research papers.
Interessen
Max Hasmann - Patents
www.freshpatents.com
Recent bibliographic sampling of Max Hasmann patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Business-Profile
Xing: Max Hasmann - Preclinical Science Leader and Translational Medicine...
Berufserfahrung, Kontaktdaten, Portfolio und weitere Infos: Erfahren Sie mehr – oder kontaktieren Sie Max Hasmann direkt bei XING.
Ausbildung
Fluorescence methods and applications : spectroscopy, imaging, and...
searchworks.stanford.edu
Stanford Libraries' official online search tool for books, media, journals, databases, government documents and more.
Bücher
brustbild eines jungen: Fotografien - ZVAB
www.zvab.com
Brustbild eines jungen Mannes mit Krawatte. Auf Karton montiert. und eine große Auswahl ähnlicher Bücher, Kunst und Sammlerstücke erhältlich auf ZVAB.com.
PLOS ONE: Direct estrogen receptor (ER) / HER family crosstalk...
journals.plos.org
Affiliation A4P Consulting Ltd, Sandwich, United Kingdom. Max Hasmann. Affiliation Roche Innovation Center Munich, Penzberg, Germany.
Wissenschaftliche Veröffentlichungen
Patents Assigned to Klinge Pharma GmbH - Justia Patents Searchpatents.justia.com › assignee › klinge-pharma-gmbh
patents.justia.com
Inventors: Elfi Biedermann, Max Hasmann, Roland Löser, Benno Rattel, Friedemann Reiter, Barbara Schein, Klaus Seibel, Klaus Vogt, Katja Wosikowski, Isabel ...
Cancer Letters | Vol 84, Issue 2, Pages (15 September 1994) |...
www.sciencedirect.com
Max Hasmann, Benno Rattel, Roland Löser. Pages : Download PDF. Article preview. select article Hyperphosphorylation of p53 induced by benzene, ...
FreiDok plus - Max Hasmann
freidok.uni-freiburg.de
{{role.value| show_role_text:"person_project_role":this}} () {{role.value| show_role_text:"person":this}} ...
Veröffentlichungen allgemein
Phase Ib study evaluating safety and clinical activity of the anti ...
link.springer.com
von A Schneeweiss · · Zitiert von: 39 — Wolfgang Jacob, Annie Moisan, Georgina Meneses-Lorente, Tomas Racek, Maurizio Ceppi, Max Hasmann and Martin Weisser own stocks of F. › article
(PDF) A Phase Ib/Ii Study of HER3-targeting Lumretuzumab in
research.amanote.com
A Phase Ib/Ii Study of HER3-targeting Lumretuzumab in Combination With Carboplatin and Paclitaxel as First-Line Treatment in Patients With Advanced
Oalib search
www.oalib.com
Abstract: ErbB2 is an important oncogenic protein involved in carcinogenesis of, among others, breast, gastric, and ovarian carcinoma.
Phase Ib study evaluating safety and clinical activity of the...
link.springer.com
· Wolfgang Jacob, Maurizio Ceppi, Max Hasmann & Martin Weisser. Pharma Research and Early Development (pRED), Roche Innovation Center Welwyn, ...
Artikel & Meinungen
Research Directory | MedNous
www.mednous.com
MedNous is a printed journal and website that covers advances in medicine in Europe
Research Directory Interviewees and Contributors | MedNouswww.mednous.com › research-directory › interview...
www.mednous.com
Filter Research Directory items by interviewee name · Robert Habib · Jennifer Hannesschlager · Max Hasmann · Phil Haworth · Phil Haworth · Matthias Heck · Peter ...
Cancer Genomics & Proteomics
www.dkfz.de
Sarcoma: Florian Haller, Abbas Agaimy, Arndt Hartmann (Erlangen) Breast cancer: Christel Herold-Mende, Andreas Schneeweiss, Clarissa Gerhäuser, Naveed Ishaque (Heidelberg), Martina Vetter, Eva Kantelhardt (Halle/Saale), Jens Timmer (Freiburg), Tim Beissbarth (Göttingen), Max Hasmann (Penzberg), Niels de Jonge (Saarbrücken)
Stromal NRG1 in luminal breast cancer defines pro-fibrotic and...
www.nature.com
· Max Hasmann. Divison of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. Elisa Espinet.
Sonstiges
WO A3 - Composition of a first non-labeled monoclonal...
patents.google.com
Application filed by Hoffmann La Roche, Max Hasmann, Helmut Lenz, Werner Scheuer Publication of WO A
BRPI A COMPOSITION OF A FIRST UNMARKED MONOCLONAL...
patents.google.com
Download PDF Find Prior Art Similar. Other languages: Portuguese; Inventor: Max Hasmann: Helmut Lenz: Werner Scheuer ... › patent
Tumor therapy with a combination of anti-her2 antibodies
patents.google.com
Application number: US ,584; Inventor: Thomas Friess: Max Hasmann: Werner Scheuer; Current Assignee (The listed assignees may be inaccurate. › patents
Max Hasmann - Entity | RPX Insightinsight.rpxcorp.com › max-hasmann
insight.rpxcorp.com
Max Hasmann has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as a defendant.
Hasmann, Max: मुफ़्त में डाउनलोड. ई-बुक पुस्तकालय. Z-Library में ऑन ...
hi.booksc.eu
Max Hasmann, Christian Klein, Georg-Burkhard Kresse. पत्रिका: Chemie in unserer Zeit. साल: भाषा: german. फ़ाइल: PDF, MB. › ...
Max Hasmann, Muenchen DE - Patent applications
www.patentsencyclopedia.com
TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY - The present invention provides a method of treating a patient suffering from relapsed HER2 positive cancer with an ...
Concepts & Developments in Flow Cytometry & Cytomics: MPI-Biochemie,...
www.classimed.de
History Flow Cytometry and Cytomics at Max-Planck-Institut für Biochemie, ... Early history of developments in flow and image cytometry, ... Max Hasmann Gerburg Wulf
(PDF) WK175, a Novel Antitumor Agent, Decreases the Intracellular...
www.academia.edu
We recently developed a class of novel antitumor agents that elicit a potent growth-inhibitory response in many tumor cells cultured in vitro. WK175, a member...
A phase 1 study of MM-111, a bispecific HER2/HER3 antibody fusion...
ouci.dntb.gov.ua
... Céline Adessi, Annie Moisan, Georgina Meneses-Lorente, Tomas Racek, Ian James, Maurizio Ceppi, Max Hasmann, Martin Weisser, Andrés Cervantes.
Adding anti-estrogen therapy further improves the efficacy of...
plos.figshare.com
posted on , 11:03 by Denis Collins, Wolfgang Jacob, Juan Miguel Cejalvo, Maurizio Ceppi, Ian James, Max Hasmann, John Crown, Andrés ...
A phase Ib/II study of HER3-targeting lumretuzumab in ...
core.ku.dk
... Mau-Soerensen and Celine Adessi and Francesca Michielin and Ian James and Maurizio Ceppi and Max Hasmann and Martin Weisser and Andr{\'e}s Cervantes",. › fitmum › export
Clinical development of HER3-targeting monoclonal antibodiespubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
von W Jacob · · Zitiert von: 33 — Authors. Wolfgang Jacob , Ian James , Max Hasmann , Martin Weisser. Affiliations. 1 Pharma Research and Early Development, Roche Innovation Center Munich, ...
Create a SciFeed alert for new publications With following keywords ...www.mdpi.com › scifeed_display
www.mdpi.com
By following authors. Juliana Bentes Hughes. Marianne Skeie Rødland. Max Hasmann. Inger Helene Madshus. Espen Stang. With settings. Email: Freq:.
(PDF) Chemopotentiating effects of a novel NAD biosynthesis...
www.academia.edu
FK866 is a novel anticancer agent that was previously shown to interfere with NAD superset+ biosynthesis by inhibition of nicotinamide...
Direct estrogen receptor (ER) / HER family crosstalk Galelink.gale.com › apps › doc › AONE
go.gale.com
Author(s): Denis Collins 1,*, Wolfgang Jacob 2, Juan Miguel Cejalvo 3, Maurizio Ceppi 2, Ian James 4, Max Hasmann 2, John Crown 1,5, Andrés Cervantes 3, ...
Flow cytometric FRET analysis of erbB receptor interaction on a...
pubmed.ncbi.nlm.nih.gov
Lateral interaction of c-erbB family receptors resulting in dimer formation is the key event initiating signal transduction. Consequently cross-activation and...
SpringerCitations - Details Page
citations.springernature.com
Max Hasmann, Benno Rattel and Roland Löser. Journal: Cancer Letters, 1994, Volume 84, Number 2, Page DOI: (94)
Chronik: Sparte Fußball - TSV Kößlarn e.V.
keiler1906.de
(kniend): Josef Obernhuber, Peter Hasmann, Max Hasmann, Josef Kaiser, Franz Obernhuber. Bereits am 10. August kam es vor der Rekord-Kulisse von › › #eswareinmal
Lumretuzumab and pertuzumab both potently inhibit HER2/HER3 signaling.
figshare.com
posted on , 11:03 by Denis Collins, Wolfgang Jacob, Juan Miguel Cejalvo, Maurizio Ceppi, Ian James, Max Hasmann, John Crown, Andrés Cervantes, ...
Molecular determinants of trastuzumab efficacy: What is their...
pubmed.ncbi.nlm.nih.gov
Authors. Pradip De , Max Hasmann, Brian Leyland-Jones. Affiliation. 1 Edith Sanford Breast Cancer Center, Sanford Research/USD, Sioux Falls, SD, USA.
sortiert nach Relevanz / Datum